Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 71 890 76 450 81 581 81 594 85 081 89 321
EBITDA 24 919 24 764 28 104 29 819 32 352 34 784
Operating profit (EBIT) 21 165 19 122 21 175 25 389 27 980 30 291
Pre-Tax Profit (EBT) 19 803 17 673 17 999 21 616 23 989 25 900
Net income 16 540 1 300 15 297 18 319 20 896 22 708
P/E ratio 19,4x 297x 23,0x 19,5x 17,3x 15,5x
EPS ( $ ) 5,93 0,47 5,61 6,72 7,58 8,48
Dividend per Share ( $ ) 3,15 3,32 3,54 3,76 4,01 4,20
Yield 2,73% 2,38% 2,74% 2,86% 3,05% 3,20%
Reference price ( $ ) 115,210 139,720 129,050 131,270 131,270 131,270
Announcement Date 01/24/2017
11:40am
01/23/2018
11:40am
01/22/2019
11:40am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt - 16 285 7 997 5 892 - -
Finance 14 781 - - - 1 151 15 943
Operating income (EBITDA) 24 919 24 764 28 104 29 819 32 352 34 784
Leverage
(Debt/EBITDA)
- 0,66x 0,28x 0,20x - -
Capital Expenditure 3 226 3 279 3 670 3 509 3 737 3 847
Book Value Per Share (BVPS) ( $ ) 26,0 21,9 22,4 23,7 25,8 28,5
Cash Flow per Share ( $ ) 6,73 7,67 8,14 8,64 10,1 10,1
Announcement Date 01/24/2017
11:40am
01/23/2018
11:40am
01/22/2019
11:40am
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 346 443 M $ -
Entreprise Value (EV) 352 335 M $ 345 293 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 19,5x 17,3x
Capitalization / Revenue 4,25x 4,07x
EV / Revenue 4,32x 4,14x
EV / EBITDA 11,8x 10,9x
Yield (DPS / Price) 2,86% 3,05%
Price to book (Price / BVPS) 5,54x 5,08x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 31,1% 32,9%
Operating Leverage (Delta EBIT / Delta Sales) x 2,39x
Net Margin (Net Profit / Revenue) 22,5% 24,6%
ROA (Net Profit / Asset) 13,3% 14,1%
ROE (Net Profit / Equities) 35,6% 35,3%
Rate of Dividend 55,9% 52,8%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   4,30% 4,39%
Cash Flow / Sales 27,9% 31,3%
Capital Intensity (Assets / Sales) 1,69x 1,74x
Financial Leverage (Net Debt / EBITDA) 0,20x -
EPS & Dividend